Navigation Links
Shawn Cross Appointed CEO of Burrill Merchant Banking Group

SAN FRANCISCO, July 28 /PRNewswire/ -- Burrill & Company, a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media, is pleased to announce that Shawn Cross has been appointed CEO of the Burrill Merchant Banking Group, effective immediately.

Mr. Cross will lead the Merchant Banking Group's strategic growth plan, which includes a broad and complementary range of services to address the needs of its clients at various stages in their growth. These include the ability to identify and acquire strategic assets and capabilities; identify and partner with companies who will share the risk and rewards of developing an asset; monetize non-strategic assets through divestiture; and access of capital through a variety of mechanisms. A cornerstone of the plan includes the establishment and development of an Institutional Equities Division.  Burrill Merchant Banking experience covers a wide range within life sciences including biotechnology, pharmaceuticals, diagnostics, drug discovery and enabling technologies, medical devices, agricultural biotechnology and nutraceuticals.

"I am encouraged by the progress we have made during the past year in evolving Burrill Merchant Banking from a sophisticated life sciences advisory business to a full-service investment banking platform," said Mr. Cross. "Overseeing our next stage of growth, which will include Merchant Banking funds that complement our venture business in addition to international expansion, is an exciting proposition. Working with Steve Burrill and the rest of the larger Burrill network has been a wonderful experience and I look forward to being part of the firm's on-going success."

"We are delighted to have Shawn lead the next phase of growth in our merchant banking operations," said G. Steven Burrill, CEO of Burrill & Company. "We see an enormous opportunity to serve the life sciences industry by accelerating the growth of our Merchant Banking business. Shawn's experience in life science investment banking makes him the ideal person to grow this business and to take advantage of the company's global experience in the life sciences."

Shawn joined the firm in June 2009 as Managing Director, Merchant Banking. He has considerable experience in life science investment banking including:

- A 13-year career beginning at Alex. Brown & Sons Inc. where he focused on growth oriented companies and completed a broad range of transactions for leading life sciences companies such as Sepracor and United Therapeutics.  

- Six years in London and New York City predominantly focused on mid and large-cap pharmaceutical companies - after Alex. Brown was acquired by Deutsche Bank AG in 1999 - including strategic advisory assignments for numerous European pharmaceutical companies such as Bayer AG in addition to book-running successful financings for emerging US companies such as Auxilium Pharmaceuticals and Sciele.

- An exclusive focus on growth-oriented life sciences companies at Thomas Weisel Partners LLC in San Francisco.

Mr. Cross received an MBA with Honors from Columbia Business School. Prior to business school, he was involved in cancer research at the University of Washington Medical School where his research on the role of p53 and solid tumor progression culminated with a first authorship in the journal Science.

About Burrill Merchant Banking

Burrill Merchant Banking assists life science companies to identify, negotiate and close strategic transactions. Service lines include:

  • Merger & Acquisitions
  • Strategic Partnering
  • Spin-Outs and Divestitures
  • Financing Advisory and Private Placement
  • Private Equity

About Burrill & Company

Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions. Burrill is also the facilitator of leading industry conferences worldwide and publisher of a range of bio-intelligence reports including the monthly Burrill Report, which tracks the progress of the global biotechnology industry and annual "State of the Industry" report.

SOURCE Burrill & Company
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Shawn Cross Joins Burrill Merchant Banking
2. A Real First for Pharma Jobs Across the Globe
3. HCL Infosystems Joins Hands With Wellogic to Roll Out Nationwide Health Information Exchange Environment Across India
4. Gilson, Inc. Selects EDL Consulting's CloudCraze For Cross-Channel Webstore Expansion in Europe
5. BioCrossroads Invests in Indianapolis Biotech Company Developing Treatments for Alzheimers Disease
6. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
7. to Increase Agricultural Productivity and Knowledge Across the African Continent
8. BioCrossroads Indiana Seed Fund Invests in Vaccine Biotech Company
9. SciVal Spotlight Gaining Momentum Across the Globe as More Universities Seek Multidisciplinary View of Research Performance
10. DuPont, Dow AgroSciences Agree to Cross License Next-Generation Soybean Herbicide Tolerant Traits
11. Data From a Head-to-Head Crossover Study Evaluating FOSRENOL(R) and Sevelamer Published Today
Post Your Comments:
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... VANCOUVER , Nov. 24, 2015 /CNW/ - iCo ... ICOTF), today reported financial results for the quarter ... are expressed in Canadian dollars and presented under ... the United States ," said Andrew ... "These advancements regarding iCo-008 are not only value ...
(Date:11/24/2015)... Global, Inc., a worldwide provider of clinical research services headquartered in ... company has set a new quarterly earnings record in Q3 of ... for Q3 of 2014 to Q3 of 2015.   ... with the establishment of an Asia-Pacific office ... Kingdom and Mexico , with the ...
(Date:11/24/2015)... LEXINGTON, Massachusetts , November 24, 2015 ... Officer, will participate in the Piper Jaffray 27 th Annual ... on Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. ... Poulton , Chief Financial Officer, will participate in the Piper Jaffray ... City , NY on Tuesday, December 1, 2015, at 8:30 ...
Breaking Biology Technology:
(Date:11/10/2015)... 10, 2015 About signature ... helps to identify and verify the identity of ... as the secure and accurate method of authentication ... particular individual because each individual,s signature is highly ... when dynamic signature of an individual is compared ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):